Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-coding RNA MAF transcriptional regulator (linc-MAF-4, also known as MAFTRR) is a chromatin-associated long non-coding RNA found primarily in human lymphocytes, particularly within CD4+ T cells[1][3]. It acts as a regulatory RNA by forming a chromatin loop that brings its locus into proximity with the promoter region of the neighboring MAF gene, recruiting chromatin modifiers such as EZH2 and LSD1 to suppress MAF transcription[1][3]. High expression of linc-MAF-4 in T helper 1 (TH1) cells is associated with silencing of MAF, a transcription factor crucial for TH2 differentiation. As a result, linc-MAF-4 promotes TH1 differentiation and represses TH2 fate. Knockdown of linc-MAF-4 skews CD4+ T cell differentiation toward the TH2 lineage, increasing expression of GATA3 and IL4. Its highly specific expression patterns suggest a potential role as a molecular regulator in immune diseases involving CD4+ T cells, including autoimmunity, allergy, and possibly cancer[1]. There are currently no drugs directly targeting linc-MAF-4 or clinical reports of its use as a biomarker or safety liability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-coding RNA MAF transcriptional regulator (linc-MAF-4).